Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose-dependent Insulinotropic Receptor (GPR119)
- Target
- GPR119
- Molecular classification
- G protein-coupled receptor, GPCR, Orphan GPCR
01
Overview
Glucose-dependent insulinotropic receptor (GPR119) is a G protein-coupled receptor primarily expressed in gastrointestinal secretory cells and pancreatic beta cells. Activation of GPR119 stimulates the secretion of incretin hormones (GLP-1 and GIP) and insulin, thereby regulating glucose metabolism. It is a promising drug target for metabolic diseases like type 2 diabetes, obesity, and fatty liver disease.
02
Mechanism of action
Activation of GPR119 leads to increased intracellular cAMP levels, stimulating the release of GLP-1, GIP, and insulin.
03
Biological functions
Signal transductionRegulation of insulin secretionRegulation of incretin hormone secretionRegulation of glucose homeostasis
04
Disease associations
Type 2 diabetesObesityFatty liver diseaseMetabolic disorders
05
Safety considerations
Potential for off-target effects due to GPCR promiscuityRisk of hypoglycemia in susceptible individuals (though considered low under normoglycemic conditions)
06
Interacting drugs
APD597
1 more in the full profile.
Beyond the preview
Go deeper on Glucose-dependent Insulinotropic Receptor (GPR119).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glucose-dependent Insulinotropic Receptor (GPR119).